Treatment of thyrotoxicosis with lithium carbonate.
D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use; D002231:Carbimazole / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006111:Graves Disease / Q000097:blood / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000188:drug therapy*; D007455:Iodine / Q000097:blood; D007457:Iodine Radioisotopes; D008094:Lithium / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010783:Photometry; D011863:Radioimmunoassay; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000187:drug effects; D013974:Thyroxine / Q000097:blood; D013997:Time Factors; D014284:Triiodothyronine / Q000097:blood
D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D014284:Triiodothyronine; D002231:Carbimazole; D007455:Iodine; D008094:Lithium; D013974:Thyroxine